| 1 |
Citicoline and COVID-19: vis-ą-vis conjectured |
|
| | Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Mohammed Alorabi, Nasser A. Hadi Al-Harcan, Maisra M. El-Bouseary, Gaber El-Saber Batiha | | | Naunyn-Schmiedeberg's Archives of Pharmacology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The role of paraoxonase and myeloperoxidase as oxidative stress markers in pregnant women with hypothyroidism |
|
| | Suat Cakina, Eren Pek, Onur Ozkavak, Deniz Kocyigit, Fatma Beyazit | | | Gynecological Endocrinology. 2022; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Impact of Sitagliptin on Non-diabetic Covid-19 Patients |
|
| | Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou, Gaber El-Saber Batiha | | | Current Molecular Pharmacology. 2022; 15(4): 683 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients |
|
| | Xia Li, Dianxuan Guo, Hualan Zhou, Youdong Hu, Xiang Fang, Ying Chen | | | Current Vascular Pharmacology. 2021; 19(6): 643 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Hypertension and its management in COVID-19 patients: The assorted view |
|
| | Gaber El-Saber Batiha, Abdulrahim Gari, Norhan Elshony, Hazem M. Shaheen, Murtala Bello Abubakar, Sherif Babatunde Adeyemi, Hayder M. Al-kuraishy | | | International Journal of Cardiology Cardiovascular Risk and Prevention. 2021; 11: 200121 | | | [Pubmed] [Google Scholar] [DOI] | |
|
